Media - Statement

News Release
For Immediate Release

Mary Borneman:

Hyland’s Affirms Safety of Its Products; Still Awaiting Data Behind FDA Warning

October, 12, 2016

We have seen recent reports related to issues linked to use of homeopathic teething tablets and gels. Hyland’s has not been made aware of any data that supports the claims in these reports. Our understanding is that the Food and Drug Administration’s investigation of these products is still ongoing. The fact is that we have not been made aware of any medical or statistical evidence to support a causal link between homeopathic teething tablets and adverse outcomes at this point. We continue to request any available information and statistics from the FDA.
Over the course of the last six years, Hyland’s has developed and now employs state-of-the-art safety and testing procedures to ensure all its baby products are safe for our youngest users. Data from that program continues to indicate our products are safe. We look forward to working in partnership with the FDA to continue providing safe and effective medicines to families around the world. We regret that such unsubstantiated information is being shared and creating concerns among consumers.


About Hyland’s
Hyland’s, Inc., a division of Standard Homeopathic Co., develops homeopathic medicines with the highest‐ quality natural ingredients, following the strictest standards of preparation. With its commitment to excellence for over a century, Hyland’s consistently provides quality and integrity in every product. From Hyland’s Baby Tiny Cold Tablets to Hyland’s Calms Forté, Hyland's cares for families at every stage of life. Consumers can trust all Hyland’s products to be natural, gentle, effective and safe for the entire family. For more information on products, visit or